Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference
PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that management will participate in investor meetings at the Citi 17th Annual BioPharma Conference on September 7 – 8, 2022 in Boston, Massachusetts. About Reata Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients … [Read more…]
